Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 15: 2449-2456, 2004
© 2004 American Society of Nephrology
doi: 10.1097/01.ASN.0000138232.68452.3B

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Himmelfarb, J.
Right arrow Articles by The PICARD Group,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Himmelfarb, J.
Right arrow Articles by The PICARD Group,
J Am Soc Nephrol 15:2449-2456, 2004
© 2004 American Society of Nephrology


CLINICAL SCIENCE

Oxidative Stress Is Increased in Critically Ill Patients with Acute Renal Failure

Jonathan Himmelfarb*,{dagger}, Ellen McMonagle{dagger}, Stephanie Freedman{dagger}, Jennifer Klenzak*, Elizabeth McMenamin{dagger}, Phuong Le{dagger}, Lara B. Pupim{ddagger}, T. Alp Ikizler{ddagger} and The PICARD Group

*Maine Medical Center, Portland, Maine; {dagger}Maine Medical Center Research Institute, Scarborough, Maine; and {ddagger}Vanderbilt University Medical Center, Nashville, Tennessee

Correspondence to Dr. Jonathan Himmelfarb, Division of Nephrology and Transplantation, Maine Medical Center, 22 Bramhall Street, Portland, ME 04102. Phone: 207-871-2417; Fax: 207-871-6306; E-mail: himmej{at}mmc.org

ABSTRACT. Patients with acute renal failure (ARF) experience a high mortality rate. Dysregulated inflammation and altered metabolism may increase oxidative stress in ARF patients. Thirty-eight patients who met the Program to Improve Care in Acute Renal Disease (PICARD) Study inclusion criteria underwent plasma protein oxidation and plasma cytokine measurements. For comparison, similar measurements were also performed in 21 critically ill patients without ARF, 28 patients with ESRD, and 49 healthy subjects. Plasma protein thiol oxidation was measured by spectrophotometry. Plasma protein carbonyl content and cytokine concentrations were measured by ELISA. Plasma protein thiol oxidation and carbonyl content were markedly different in ARF patients compared with healthy subjects, ESRD patients, and critically ill patients (P < 0.001 in all cases). There were significant but less marked differences in plasma protein oxidation between ESRD patients and critically ill patients compared with healthy subjects. Plasma protein thiol oxidation in ARF patients improved with dialysis (P < 0.001); however, there was significant plasma oxidant reaccumulation during the interdialytic period (P < 0.001) not due to rebound equilibration of compartmentalized solutes. Plasma proinflammatory cytokine levels were significantly higher (P < 0.05) in ARF patients and critically ill patients than in healthy subjects. Plasma protein oxidation is markedly increased in ARF patients compared with healthy subjects, ESRD patients, and critically ill patients. Increased oxidative stress may be an important target for nutritional and pharmacologic therapy in ARF patients.




This article has been cited by other articles:


Home page
CJASNHome page
S. S. Waikar, K. D. Liu, and G. M. Chertow
Diagnosis, Epidemiology and Outcomes of Acute Kidney Injury
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 844 - 861.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. L. Mehta
Glycemic Control and Critical Illness: Is the Kidney Involved?
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2623 - 2627.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. D. Nolin, K. Appiah, S. A. Kendrick, P. Le, E. McMonagle, and J. Himmelfarb
Hemodialysis Acutely Improves Hepatic CYP3A4 Metabolic Activity
J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2363 - 2367.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Devarajan
Update on Mechanisms of Ischemic Acute Kidney Injury
J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1503 - 1520.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Nitescu, S.-E. Ricksten, N. Marcussen, B. Haraldsson, U. Nilsson, S. Basu, and G. Guron
N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1240 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Basi, L. B. Pupim, E. M. Simmons, M. T. Sezer, Y. Shyr, S. Freedman, G. M. Chertow, R. L. Mehta, E. Paganini, J. Himmelfarb, et al.
Insulin resistance in critically ill patients with acute renal failure
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F259 - F264.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP